IS4774A - Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum - Google Patents
Lyfjafræðilegar samsetningar með D-vítamín hliðstæðumInfo
- Publication number
- IS4774A IS4774A IS4774A IS4774A IS4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A IS 4774 A IS4774 A IS 4774A
- Authority
- IS
- Iceland
- Prior art keywords
- analogs
- vitamin
- pharmaceutical formulations
- formulations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19549243A DE19549243A1 (de) | 1995-12-21 | 1995-12-21 | Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga |
| PCT/EP1996/005856 WO1997023242A1 (de) | 1995-12-21 | 1996-12-20 | Pharmazeutische präparate mit vitamin d-analoga |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4774A true IS4774A (is) | 1998-06-15 |
Family
ID=7781710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4774A IS4774A (is) | 1995-12-21 | 1998-06-15 | Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0869819A1 (is) |
| JP (1) | JP2000502733A (is) |
| KR (1) | KR19990076637A (is) |
| CN (1) | CN1207687A (is) |
| AU (1) | AU1306997A (is) |
| CA (1) | CA2241205A1 (is) |
| DE (1) | DE19549243A1 (is) |
| HU (1) | HUP9903935A3 (is) |
| IL (1) | IL125020A0 (is) |
| IS (1) | IS4774A (is) |
| NO (1) | NO982874L (is) |
| WO (1) | WO1997023242A1 (is) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
| US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
| US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
| GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
| DE102005017775A1 (de) * | 2005-04-13 | 2006-10-19 | Schering Ag | Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins |
| CA2882048C (en) | 2006-02-03 | 2020-03-24 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| DK3357496T3 (da) | 2006-06-21 | 2020-05-11 | Opko Ireland Global Holdings Ltd | Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel |
| KR100822133B1 (ko) * | 2006-11-06 | 2008-04-15 | 한미약품 주식회사 | 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제 |
| CA2683628C (en) | 2007-04-25 | 2018-03-06 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
| DK2148661T3 (da) | 2007-04-25 | 2013-03-25 | Cytochroma Inc | Orale præparater med kontrolleret afgivelse omfattende vitamin D-forbindelse og voksagtig bærer |
| JP2010525080A (ja) | 2007-04-25 | 2010-07-22 | プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー | 慢性腎臓病における続発性副甲状腺機能亢進症の安全かつ効果的な治療および予防方法 |
| CA2684778C (en) | 2007-04-25 | 2017-09-05 | Cytochroma Inc. | Methods and compounds for vitamin d therapy |
| EP3112476B1 (en) | 2008-04-02 | 2023-08-02 | EirGen Pharma Ltd. | Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders |
| WO2011123476A1 (en) | 2010-03-29 | 2011-10-06 | Cytochroma Inc. | Methods and compositions for reducing parathyroid levels |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
| KR20180123100A (ko) | 2016-03-28 | 2018-11-14 | 옵코 아일랜드 글로벌 홀딩스 리미티드 | 비타민 d 치료 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177586B (en) * | 1978-12-19 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | New process for preparing stable inclusion complexes of vitamine d with cyclodextrin |
| JPS5910562A (ja) * | 1982-07-07 | 1984-01-20 | Teijin Ltd | プレ−１α−ヒドロキシコレカルシフエロ−ル類の製造法 |
| JPS5936656A (ja) * | 1982-08-23 | 1984-02-28 | Teijin Ltd | 新規包接化合物及びそれを活性成分とする薬剤 |
| JPS60120812A (ja) * | 1983-12-02 | 1985-06-28 | Teijin Ltd | 糖尿病性骨減少症治療剤 |
| DK0437225T3 (da) * | 1990-01-10 | 1994-06-27 | Hoffmann La Roche | Topiske præparater |
| IL107185A (en) * | 1992-10-06 | 1998-02-22 | Schering Ag | History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them |
-
1995
- 1995-12-21 DE DE19549243A patent/DE19549243A1/de not_active Withdrawn
-
1996
- 1996-12-20 EP EP96944669A patent/EP0869819A1/de not_active Withdrawn
- 1996-12-20 KR KR1019980704745A patent/KR19990076637A/ko not_active Application Discontinuation
- 1996-12-20 WO PCT/EP1996/005856 patent/WO1997023242A1/de not_active Application Discontinuation
- 1996-12-20 CN CN96199734A patent/CN1207687A/zh active Pending
- 1996-12-20 HU HU9903935A patent/HUP9903935A3/hu unknown
- 1996-12-20 JP JP9523335A patent/JP2000502733A/ja active Pending
- 1996-12-20 AU AU13069/97A patent/AU1306997A/en not_active Abandoned
- 1996-12-20 IL IL12502096A patent/IL125020A0/xx unknown
- 1996-12-20 CA CA002241205A patent/CA2241205A1/en not_active Abandoned
-
1998
- 1998-06-15 IS IS4774A patent/IS4774A/is unknown
- 1998-06-19 NO NO982874A patent/NO982874L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE19549243A1 (de) | 1997-06-26 |
| WO1997023242A1 (de) | 1997-07-03 |
| IL125020A0 (en) | 1999-01-26 |
| CA2241205A1 (en) | 1997-07-03 |
| JP2000502733A (ja) | 2000-03-07 |
| NO982874D0 (no) | 1998-06-19 |
| KR19990076637A (ko) | 1999-10-15 |
| HUP9903935A2 (hu) | 2000-03-28 |
| NO982874L (no) | 1998-08-20 |
| EP0869819A1 (de) | 1998-10-14 |
| HUP9903935A3 (en) | 2000-05-29 |
| AU1306997A (en) | 1997-07-17 |
| CN1207687A (zh) | 1999-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610153A (pt) | Formulações farmacêuticas | |
| BR9611626A (pt) | Formulações farmacéuticas | |
| DK0585252T3 (da) | Farmaceutiske formuleringer | |
| DK481989D0 (da) | Farmaceutiske formuleringer | |
| DE69615887T2 (de) | Oral anzuwendende Arzneizubereitung enthaltend Olanzapin | |
| NO962606L (no) | Farmasöytisk sammensetning | |
| NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| IS4774A (is) | Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum | |
| PT808833E (pt) | Analogos da vitamina d3 | |
| ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
| DE69614407T2 (de) | Pharmazeutische zusammensetzungen | |
| ID16781A (id) | Formulasi-formulasi farmasi | |
| LV11727A (lv) | Farmaceitiska kompozicija | |
| TR199501082A2 (tr) | Farmasötik formülasyonlar. | |
| ITMI941169A0 (it) | Formulazioni farmaceutiche | |
| FI973280A (fi) | Farmaseuttinen koostumus | |
| FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
| DK0876367T3 (da) | Trans apovincaminsyreesterderivater som lægemidler | |
| BR9605777A (pt) | Composição farmacêutica | |
| NO964309D0 (no) | Farmasöytisk sammensetning | |
| SE9502453D0 (sv) | Drug formulations | |
| SE9404467D0 (sv) | Drug formulations | |
| ATE239508T1 (de) | Partikulare arzneiform | |
| FR2736803B1 (fr) | Composition vitaminee stabilisee |